Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Optimizing Adult Vaccination Ecosystem in IndiaRelease Date:Quality Improvement Vaccines India Evidence Based Safety Contextualization of JAK inhibitors in the Treatment of Moderate to Severe Atopic DermatitisRelease Date:Education Inflammation & Immunology China, France, Germany, Italy, Japan, Korea, Spain, USA Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology Spain Optimizing Clinical Care Delivery for Patients with Multiple Myeloma Receiving Bispecific AntibodiesRelease Date:Quality Improvement Oncology All Enhancing HCP Education in Maternal VaccinationRelease Date:Education Vaccines Saudi Arabia Diagnosis and Treatment of Cancer CachexiaRelease Date:Education Oncology All Evidence-Based Education on the Potential Impact of a Generic JAK Inhibitor on the Management of Rheumatologic DiseasesRelease Date:Education Inflammation & Immunology USA B-cell Maturation Antigen (BCMA) Bi-Specific Antibodies (BsAbs) in Relapsed/Refractory Multiple Myeloma (RRMM)Release Date:Education Oncology USA Education on Mechanism of Action of JAK3 and TEC Family Kinase Role in Alopecia AreataRelease Date:Education Inflammation & Immunology USA 2026 Hemophilia Fellowship – United StatesRelease Date:Fellowship Rare Disease All Pediatric Pneumococcal Disease and Serotype Distribution: Surveillance Studies in Saudi ArabiaRelease Date:Research Vaccines Saudi Arabia Optimising Ulcerative Colitis Care: Bridging Knowledge Gaps, Integrating Biomarker-Based Strategies, and Advancing EquityRelease Date:Education Inflammation & Immunology Australia Title Grant Type Focus Area Country Application Due Date Cardiac Transthyretin Amyloid (ATTR) FellowshipRelease Date:Partner: International Society of AmyloidosisFellowship Rare Disease All Clinical Diagnosis and Management of EndometriosisEducation Internal Medicine USA Management of Uterine FibroidsEducation Internal Medicine USA Rapid Education on Drug-Drug Interactions in COVID-19 Outpatient TreatmentRelease Date:Education Hospital USA 2023 Global Migraine ASPIRERelease Date:Research Internal Medicine All Promoting Pain Treatment in Musculoskeletal PainRelease Date:Education Internal Medicine Japan Improve the Treatment Environment for Cancer Pain PatientsRelease Date:Education Internal Medicine Japan LMIC Pharmacovigilance EducationRelease Date:Education Patient Safety Kenya, Lesotho, Swaziland Knowledge Gaps in Managing Obesity and COVID-19Release Date:Education Hospital USA Immunotherapy in Urothelial Carcinoma (USA, Europe, Asia, Latin America, Canada, and Global)Release Date:Partner: Merck KGaA, Darmstadt, Germany, EMD SeronoEducation Oncology All Promoting timely diagnosis of ATTR-CM in China Competitive Grant Program - internal Pfizer review processRelease Date:Quality Improvement Rare Disease China Quality Improvement Initiatives to Address Healthcare Barriers for Cardiac AmyloidosisRelease Date:Partner: National Medical AssociationQuality Improvement Rare Disease USA